Table 2.
Association of identified markers with chemoresistance
| OCCC | HGSC | |||||
|---|---|---|---|---|---|---|
| PR (n = 15) | PS (n = 113) | p value | PR (n = 2) | PS (n = 79) | p value | |
| AOC1 | 6 (40.0%) | 74 (65.5%) | 0.055 | 0 (0) | 9 (11.4%) | 1.000 |
| GPX3 | 4 (26.7%) | 67 (59.3%) | 0.017a | 0 (0) | 3 (3.8%) | 1.000 |
| LEFTY1 | 14 (93.3%) | 105 (92.9%) | 1.000 | 2 (100.0%) | 36 (45.6%) | 0.217 |
| S100A2 | 1 (6.7%) | 3 (2.7%) | 0.396 | 1 (50.0%) | 26 (32.9%) | 1.000 |
| CRABP2 | 7 (46.7%) | 34 (30.1%) | 0.318 | 2 (100.0%) | 72 (91.1%) | 1.000 |
| WFDC2 | 1 (6.7%) | 31 (27.2%) | 0.158 | 2 (100.0%) | 54 (68.4%) | 1.000 |
Values indicate the number of patients for whom samples showed high immunohistochemical staining (percentages)
PR: platinum-resistant; PS: platinum-sensitive
a: statistically significant